You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 23, 2024

Details for New Drug Application (NDA): 210807

✉ Email this page to a colleague

« Back to Dashboard

NDA 210807 describes DELSTRIGO, which is a drug marketed by Msd Merck Co and is included in one NDA. It is available from one supplier. There are three patents protecting this drug. Additional details are available on the DELSTRIGO profile page.

The generic ingredient in DELSTRIGO is doravirine; lamivudine; tenofovir disoproxil fumarate. One supplier is listed for this compound. Additional details are available on the doravirine; lamivudine; tenofovir disoproxil fumarate profile page.
Summary for 210807
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for 210807
Generic Entry Date for 210807*:
Constraining patent/regulatory exclusivity:

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Suppliers and Packaging for NDA: 210807
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DELSTRIGO doravirine; lamivudine; tenofovir disoproxil fumarate TABLET;ORAL 210807 NDA Merck Sharp & Dohme LLC 0006-5007 0006-5007-01 30 TABLET, FILM COATED in 1 BOTTLE (0006-5007-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG;300MG;300MG
Approval Date:Aug 30, 2018TE:RLD:Yes
Regulatory Exclusivity Expiration:Jan 27, 2025
Regulatory Exclusivity Use:NEW PATIENT POPULATION
Patent:⤷  Sign UpPatent Expiration:Nov 29, 2036Product Flag?YSubstance Flag?Delist Request?
Patent:⤷  Sign UpPatent Expiration:Nov 29, 2036Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.